GARDEN CITY, N.Y. and HAMILTON, Bermuda, April 19, 2023 (GLOBE NEWSWIRE) -- Beyond Cancer, Ltd., an affiliate of Beyond Air, Inc. (NASDAQ: XAIR) that is developing ultra-high concentration nitric ...

50,000 or 100,000 ppm UNO alone or in combination with anti-mCTLA-4 more than tripled antigen specific central memory T-cell response versus anti-mCTLA-4 alone Pooled analysis of combination studies ...

A first-in-human clinical trial is expected to being in the US in 2026. The Food and Drug Administration (FDA) has granted Orphan Drug designation to BA-102 for the treatment of Phelan-McDermid ...

Nitric Oxide (NO) is a potent molecule, naturally synthesized in the human body, proven to play a critical role in a broad array of biological functions. In the airways, NO targets the vascular smooth ...

Inhaled nitric oxide (iNO) therapy is used in neonatal care as a selective pulmonary vasodilator to improve oxygenation and reduce pulmonary vascular resistance. In preterm infants, the application of ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Arterial oxygenation in critically ill adults with COVID ...

WARREN, N.J., March 30, 2020 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Beyond Air has received FDA approval for ...

UNO in combination with anti-PD-1 treatment results in a higher percentage of tumor free mice and prolonged survival in CT26 tumor bearing mice GARDEN CITY, N.Y. and HAMILTON, Bermuda, Nov. 10, 2022 ...

Researchers have understood for decades that some forms of deafness are inherited, yet until now, few of those genetic clues ...